logo

Science Feeds -


Combination of bevacizumab and lomustine with first recurrence of glioblastoma prolongs progression-free survival, but not overall survival Combination of bevacizumab and lomustine with first recurrence of glioblastoma prolongs progression-free survival, but not overall survival

- (Science Daily) - 1 years, 8 months ago...

Bevacizumab treatment in patients with progressive glioblastoma, despite prolonged progression-free survival, does not confer a survival advantage, report scientists....

see complete article.

Similar recent news articles...

-- Sorry, no results.

Popular news